Probiotic for inhibiting growth of Proteus mirabilis, and fermentation broth and application thereof

A method for treating atherosclerosis in a subject in need thereof, comprising:

• inoculating a probiotic into a fermentation medium followed by anaerobic culture to obtain a fermentation broth;
• and
• administering a therapeutically effective amount of the fermentation broth to the subject;
• wherein the probiotic comprises a microorganism selected from the group consisting of Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus reuteri, Bifidobacterium animalis subsp. lactis, Bifidobacterium infantis, Bifidobacterium bifidum and a combination thereof;
• and
• the Lactobacillus rhamnosus is Lactobacillus rhamnosus AI-11 assigned accession CGMCC No. 21745;
• the Lactobacillus fermentum is Lactobacillus fermentum AI-25 assigned accession CGMCC No. 21746;
• the Lactobacillus plantarum is Lactobacillus plantarum AI-66 assigned accession CGMCC No. 21741;
• the Lactobacillus casei is Lactobacillus casei AI-12 assigned accession CGMCC No. 21742;
• the Lactobacillus acidophilus is Lactobacillus acidophilus AI-32 assigned accession CGMCC No. 21743;
• the Lactobacillus paracasei is Lactobacillus paracasei AI-62 assigned accession CGMCC No. 21744;
• the Lactobacillus reuteri is Lactobacillus reuteri AI-70 assigned accession CGMCC No. 21748;
• the Bifidobacterium animalis subsp. lactis is Bifidobacterium animalis subsp. lactis AI-01 assigned accession CGMCC No. 21747;
• the Bifidobacterium infantis is Bifidobacterium infantis AI-20 assigned accession CGMCC No. 21779;
• and
• the Bifidobacterium bifidum is Bifidobacterium bifidum AI-91 assigned accession CGMCC No. 21780.